348 — China Healthwise Holdings Share Price
Last trade - 00:00- HK$40.07m
- HK$94.68m
- HK$146.32m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.11 | ||
| Price to Tang. Book | 9.11 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.27 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1832.16% | ||
| Return on Equity | -188.13% | ||
| Operating Margin | -84.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | HK$m | 451.62 | 137.85 | 170.08 | 142.06 | 146.32 | n/a | n/a | -23.57% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CHINA HEALTHWISE HOLDINGS LIMITED, formerly Haier Healthwise Holdings Limited, is a Hong Kong-based investment holding company principally engaged in toy and electronic products businesses. The Company’s main businesses include the development, design, manufacture and sales of toys, commercial kitchen products and consumer electronic products. It operates through three segments, including Manufacturing and Sale of Toys segment, Sale of Consumer Electronic Products segment, as well as Manufacturing and Sale of Commercial Kitchen Products segment. Its products include water purifiers, air conditioners, washing machines and infant formula preparation kits, among others.
Directors
- Hong Wai Lei CHM (48)
- Kwok Wai Cheung VCH (54)
- Alex Leung VCH (38)
- Ming Wan Lo EDR (31)
- Chi Keung Tse EDR (35)
- Huixia Yuan EDR (37)
- Yuk Hung Leung OTH (39)
- Ki Yin Ng OTH (60)
- Bruce Oravec OTH (71)
- Hok Lim Lai NID (61)
- Wai Hung Lien NID (53)
- Tak Chuen Wong NID
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 1st, 1970
- Public Since
- September 30th, 1997
- No. of Employees
- 100
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 770,481,000
- Address
- Lung Cheong Building
- Web
- https://www.healthwisehk.com/
- Phone
- +852 null22688248
- Auditors
- HLB Hodgson Impey Cheng
Upcoming Events for 348
Similar to 348
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:05 UTC, shares in China Healthwise Holdings are trading at HK$0.05. This share price information is delayed by 15 minutes.
Shares in China Healthwise Holdings last closed at HK$0.05 and the price had moved by -59.69% over the past 365 days. In terms of relative price strength the China Healthwise Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -57.93% over the past year.
There is no consensus recommendation for this security.
China Healthwise Holdings does not currently pay a dividend.
China Healthwise Holdings does not currently pay a dividend.
China Healthwise Holdings does not currently pay a dividend.
To buy shares in China Healthwise Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.05, shares in China Healthwise Holdings had a market capitalisation of HK$40.07m.
Here are the trading details for China Healthwise Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 348
Based on an overall assessment of its quality, value and momentum China Healthwise Holdings is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Healthwise Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -21.84%.
As of the last closing price of HK$0.05, shares in China Healthwise Holdings were trading -3.84% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The China Healthwise Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
China Healthwise Holdings' management team is headed by:
- Hong Wai Lei - CHM
- Kwok Wai Cheung - VCH
- Alex Leung - VCH
- Ming Wan Lo - EDR
- Chi Keung Tse - EDR
- Huixia Yuan - EDR
- Yuk Hung Leung - OTH
- Ki Yin Ng - OTH
- Bruce Oravec - OTH
- Hok Lim Lai - NID
- Wai Hung Lien - NID
- Tak Chuen Wong - NID